Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats

Yoshihisa Kitamura, Takahiko Yagi, Kouhei Kitagawa, Kazuaki Shinomiya, Hiromu Kawasaki, Masato Asanuma, Yutaka Gomita

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

The dopamine reuptake inhibitor bupropion has clinically been proven to improve depression and treatment-resistant depression. We examined its influence on the duration of immobility during the forced swim test in adrenocorticotropic hormone (ACTH)-treated rats and further analyzed the possible role of dopamine receptors in this effect. Additionally, the mechanism by which bupropion acts in this model was explored specifically in relation to the site of action through the use of microinjections into the medial prefrontal cortex and nucleus accumbens. Bupropion significantly decreased the duration of immobility in normal and ACTH-treated rats. This effect was blocked by D2 and D3 receptor antagonists in normal rats. Furthermore, infusions of bupropion into the nucleus accumbens, but not medial prefrontal cortex, decreased the immobility of normal and ACTH-treated rats during the forced swim test. Bupropion treatment plus repeated ACTH treatment significantly increased the extracellular dopamine concentration. These findings suggest the antidepressant-like effect of bupropion to be related to levels of dopamine in the rat nucleus accumbens.

Original languageEnglish
Pages (from-to)151-158
Number of pages8
JournalNaunyn-Schmiedeberg's Archives of Pharmacology
Volume382
Issue number2
DOIs
Publication statusPublished - Aug 2010

Fingerprint

Bupropion
Nucleus Accumbens
Adrenocorticotropic Hormone
Dopamine
Prefrontal Cortex
Dopamine Uptake Inhibitors
Treatment-Resistant Depressive Disorder
Dopamine Receptors
Microinjections
Antidepressive Agents
Depression
Therapeutics

Keywords

  • Bupropion
  • Dopamine receptor
  • Dopamine release
  • Forced swim test
  • Nucleus accumbens
  • Treatment-resistant depression

ASJC Scopus subject areas

  • Pharmacology

Cite this

Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. / Kitamura, Yoshihisa; Yagi, Takahiko; Kitagawa, Kouhei; Shinomiya, Kazuaki; Kawasaki, Hiromu; Asanuma, Masato; Gomita, Yutaka.

In: Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 382, No. 2, 08.2010, p. 151-158.

Research output: Contribution to journalArticle

Kitamura, Yoshihisa ; Yagi, Takahiko ; Kitagawa, Kouhei ; Shinomiya, Kazuaki ; Kawasaki, Hiromu ; Asanuma, Masato ; Gomita, Yutaka. / Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats. In: Naunyn-Schmiedeberg's Archives of Pharmacology. 2010 ; Vol. 382, No. 2. pp. 151-158.
@article{d7df2f0ffc4b47b99bc341202ffb97fa,
title = "Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats",
abstract = "The dopamine reuptake inhibitor bupropion has clinically been proven to improve depression and treatment-resistant depression. We examined its influence on the duration of immobility during the forced swim test in adrenocorticotropic hormone (ACTH)-treated rats and further analyzed the possible role of dopamine receptors in this effect. Additionally, the mechanism by which bupropion acts in this model was explored specifically in relation to the site of action through the use of microinjections into the medial prefrontal cortex and nucleus accumbens. Bupropion significantly decreased the duration of immobility in normal and ACTH-treated rats. This effect was blocked by D2 and D3 receptor antagonists in normal rats. Furthermore, infusions of bupropion into the nucleus accumbens, but not medial prefrontal cortex, decreased the immobility of normal and ACTH-treated rats during the forced swim test. Bupropion treatment plus repeated ACTH treatment significantly increased the extracellular dopamine concentration. These findings suggest the antidepressant-like effect of bupropion to be related to levels of dopamine in the rat nucleus accumbens.",
keywords = "Bupropion, Dopamine receptor, Dopamine release, Forced swim test, Nucleus accumbens, Treatment-resistant depression",
author = "Yoshihisa Kitamura and Takahiko Yagi and Kouhei Kitagawa and Kazuaki Shinomiya and Hiromu Kawasaki and Masato Asanuma and Yutaka Gomita",
year = "2010",
month = "8",
doi = "10.1007/s00210-010-0521-x",
language = "English",
volume = "382",
pages = "151--158",
journal = "Naunyn-Schmiedeberg's Archives of Pharmacology",
issn = "0028-1298",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - Effects of bupropion on the forced swim test and release of dopamine in the nucleus accumbens in ACTH-treated rats

AU - Kitamura, Yoshihisa

AU - Yagi, Takahiko

AU - Kitagawa, Kouhei

AU - Shinomiya, Kazuaki

AU - Kawasaki, Hiromu

AU - Asanuma, Masato

AU - Gomita, Yutaka

PY - 2010/8

Y1 - 2010/8

N2 - The dopamine reuptake inhibitor bupropion has clinically been proven to improve depression and treatment-resistant depression. We examined its influence on the duration of immobility during the forced swim test in adrenocorticotropic hormone (ACTH)-treated rats and further analyzed the possible role of dopamine receptors in this effect. Additionally, the mechanism by which bupropion acts in this model was explored specifically in relation to the site of action through the use of microinjections into the medial prefrontal cortex and nucleus accumbens. Bupropion significantly decreased the duration of immobility in normal and ACTH-treated rats. This effect was blocked by D2 and D3 receptor antagonists in normal rats. Furthermore, infusions of bupropion into the nucleus accumbens, but not medial prefrontal cortex, decreased the immobility of normal and ACTH-treated rats during the forced swim test. Bupropion treatment plus repeated ACTH treatment significantly increased the extracellular dopamine concentration. These findings suggest the antidepressant-like effect of bupropion to be related to levels of dopamine in the rat nucleus accumbens.

AB - The dopamine reuptake inhibitor bupropion has clinically been proven to improve depression and treatment-resistant depression. We examined its influence on the duration of immobility during the forced swim test in adrenocorticotropic hormone (ACTH)-treated rats and further analyzed the possible role of dopamine receptors in this effect. Additionally, the mechanism by which bupropion acts in this model was explored specifically in relation to the site of action through the use of microinjections into the medial prefrontal cortex and nucleus accumbens. Bupropion significantly decreased the duration of immobility in normal and ACTH-treated rats. This effect was blocked by D2 and D3 receptor antagonists in normal rats. Furthermore, infusions of bupropion into the nucleus accumbens, but not medial prefrontal cortex, decreased the immobility of normal and ACTH-treated rats during the forced swim test. Bupropion treatment plus repeated ACTH treatment significantly increased the extracellular dopamine concentration. These findings suggest the antidepressant-like effect of bupropion to be related to levels of dopamine in the rat nucleus accumbens.

KW - Bupropion

KW - Dopamine receptor

KW - Dopamine release

KW - Forced swim test

KW - Nucleus accumbens

KW - Treatment-resistant depression

UR - http://www.scopus.com/inward/record.url?scp=77955552059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955552059&partnerID=8YFLogxK

U2 - 10.1007/s00210-010-0521-x

DO - 10.1007/s00210-010-0521-x

M3 - Article

C2 - 20526847

AN - SCOPUS:77955552059

VL - 382

SP - 151

EP - 158

JO - Naunyn-Schmiedeberg's Archives of Pharmacology

JF - Naunyn-Schmiedeberg's Archives of Pharmacology

SN - 0028-1298

IS - 2

ER -